DRREDDY

gets nod to make generic semaglutide for weight loss

Laboratories is set to launch generic semaglutide, a popular weight loss drug. An expert committee has approved their proposal. The company plans to market the drug as soon as Novo Nordisk's patent expires early next year. This move aims to tap into a growing market for obesity and diabetes management. Dr Reddy's is preparing for a competitive launch.